Observational studyHepatology international2023
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
Wei Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it